---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-035644"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T15:15:51.313480+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics closes $60M private placement and effects 1-for-20 reverse stock split

## Summary
- Private placement raised ~$60M via 8.57M shares at $7.00 each plus warrants for 12.86M shares at $7.70.
- Warrants expire March 18, 2029; exercise price $7.70 per share.
- 1-for-20 reverse stock split effective March 13, 2024; authorized shares reduced to 60M.
- After split and before placement, ~13.0M shares outstanding; securities sold under Rule 506 exemption.

## SEC filing metadata
- accession: 0001104659-24-035644
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/0001104659-24-035644-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/tm249047d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-035644
- JSON: https://secwatch.observer/filing/0001104659-24-035644.json
- Plain text: https://secwatch.observer/filing/0001104659-24-035644.txt

## Key facts
- Governance Changes
  Outlook Therapeutics, Inc.: Effected a 1-for-20 reverse stock split and proportionate reduction in authorized shares of Common Stock via Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-03-13).
  - Change: charter amendment
  - Effective: 2024-03-13
  source text: Effective March 13, 2024 at 5:00 p.m. Eastern Time, the Company effected a 1-for-20 reverse stock split and proportionate reduction in the number of authorized shares of Common Stock pursuant to a Certificate of Amendment of the Amended and Restated Certificate of Incorporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/0001104659-24-035644-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.